Jeena Sikho Lifecare Limited — PPTs, 09-08-2026: Investor Presentation

Here's a concise summary of Jeena Sikho Lifecare's Q1 FY27 Investor Presentation:

1. **Business Performance:** JSLL kicked off FY27 with robust growth. Revenue from Operations surged 29% YoY to ₹224.40 Cr, driven by higher patient footfalls and an expanded service network. Profit After Taxes grew 28% to ₹65.69 Cr. The Ayurveda Healthcare Products business was a standout, growing 47% YoY, while Healthcare Services saw Panchkarma revenue up 13% and IPD volumes up 33%.

2. **Growth Drivers or Strategy:** The company is focused on strengthening its product portfolio and leveraging its integrated healthcare ecosystem for cross-selling. A key strategy is the capital-light model and network expansion, with 2,400 operational beds and 450 more in the pipeline.

3. **Recent Developments:** The INJK Water Device, launched in Dec 2024, became a top product. JSLL is expanding into ultra-luxury wellness with its first resort signed in Manali, featuring 108 rooms and plans for 22 villas.

4. **Key Financial Metrics:** Q1FY27 Revenue from Operations: ₹224.40 Cr (+29% YoY). EBITDA: ₹92.11 Cr (+17% YoY). Profit After Taxes: ₹65.69 Cr (+28% YoY). Basic EPS: ₹5.28 (+45% QoQ, +28% YoY).

5. **Management Commentary / Outlook:** Management highlighted strong demand across both verticals and an expanding capacity, positioning JSLL well to sustain its growth trajectory by deepening market presence and increasing treatment capacity. They champion a "Disease-Free, Drug-Free Bharat" through natural wellness.